Oncowitan logo (white)
  • About us
  • Our offer
    • Scientific writing & evaluation
    • Pharma projects
    • CDMO support
  • News
    • CDMO
    • Publications
  • [Gallery]

Gallery

Gallery

Biphedrine® (ephedrine), from Laboratoires Bouchara (Paris), 1969

(more…)

By Christian Bailly, 2 years14 May 2024 ago
Gallery

Inadrox® (Sodium iodide, hydroxocobalamin and thiamine), from Laboratoires Logeais (Paris), 1971

(more…)

By Christian Bailly, 2 years14 May 2024 ago
Gallery

Hepatoum® (hydroalcoholic extracts of Curcuma longa and Anemone pulsatilla), from Laboratoires Hepatoum (Saint-Yorre, France), 1972

(more…)

By Christian Bailly, 2 years14 May 2024 ago
Gallery

Cortiphénicol® (prednisolone, chloramphenicol), from Laboratoires Bouchara (Paris, Fr), 1971

(more…)

By Christian Bailly, 2 years25 April 2024 ago
Gallery

Liotripsil® (trypsin and α-chymotrypsin), from Laboratoires Lepetit (Suresnes, Fr), 1971

(more…)

By Christian Bailly, 2 years6 April 2024 ago
Gallery

Sonuctane® (Vinbarbital, secobarbital), from Laboratoires Bottu (Paris), 1971

(more…)

By Christian Bailly, 2 years17 March 2024 ago
News-Publications

New publication: The diverse mitochondrial functions of the small GTPase protein Rac1.

(more…)

By Christian Bailly, 2 years11 March 2024 ago
Gallery

Vasculat® (1-(4-oxyphenyl)-1-oxy-2-n-butylamino-ethane sulfate), from Laboratoires Boehringer Ingelheim (Clichy, Fr), 1971

(more…)

By Christian Bailly, 2 years2 March 2024 ago
Gallery

Alpolone® (Theophylline, prednisolone, acetylsalicylic acid, promethazine, butobarbital) from Laboratoires Biosedra (Malakoff, Fr), 1972

(more…)

By Christian Bailly, 2 years11 February 2024 ago
Gallery

Contrasthényl® (vitamin B6, aspartate), from Laboratoires Biosedra (Malakoff, Fr), 1971

(more…)

By Christian Bailly, 2 years8 February 2024 ago

Posts navigation

Previous 1 … 6 7 8 … 28 Next
Search
  • Our partners
  • Contact
  • Legal notice
Hestia | Developed by ThemeIsle
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.